Skip to content
Medical Health Aged Care, Women

The Christmas gift that keeps giving: The Australian Women’s Health Diary

Breast Cancer Trials 2 mins read

Angela was just 38 years old when she was diagnosed with breast cancer, while on a road trip around Australia. Forced to cut her dream tour with her husband short, she had surgery for stage 2 Luminal A breast cancer within a week of being diagnosed.

Julie was 43 when she was told she had hormone-sensitive, stage 3 breast cancer. Working full-time and caring for her two young children, her intensive schedule of chemotherapy, surgery and radiation was particularly tough in the midst of Covid lockdowns.

Wendy was diagnosed in April 2024, at age 63. With her daughter’s wedding imminent and upcoming travel plans laid, she was keen to get back to the life she’d planned as quickly as possible.

Unified by their breast cancer diagnoses, these three women have something else in common – they’re all featured in the 2026 Australian Women’s Health Diary, which raises vital funds for breast cancer research. 

In a convenient A5 size and with all the essential features, the diary is a resource of reliable health and wellbeing information, packed with motivational tips, diet, exercise, and skincare advice, a health checklist, budget planner, and more - perfect for that Christmas gift list. 

For 47 years, the work of Breast Cancer Trials has improved the treatment of breast cancer, led to changes in the way breast cancer is managed and has saved thousands of lives. 

Deaths from breast cancer have fallen 30% over the past 20 years, which is largely due to new treatments like Herceptin, Exemestane, Letrozole and Tamoxifen identified through the Breast Cancer Trials research program. However, more research is still needed. In Australia, 58 people are diagnosed with breast cancer each day and a further nine lose their lives to the disease.

“Our significant breakthroughs have been possible thanks to the support of the many Australians who buy the Australian Women’s Health Diary each year,” explained Ms Julie Callaghan, Chief Operating Officer – Fundraising and Philanthropy at Breast Cancer Trials. “But more research is urgently needed to ensure every person, with every type of breast cancer, gets the treatment they need. Support for this diary is a win-win – it’s the perfect organiser for you and a special gift for a loved one, and all proceeds support our clinical trials research to identify new treatments and prevention strategies.”

Priced at $19.99, the 2026 Australian Women’s Health Diary is available nationally from newsagents, selected Woolworths, participating Post Offices and online at www.womenshealthdiary.com.au.

 


About us:

Founded in 1978, Breast Cancer Trials conducts a multicentre national and international clinical trials research program into the treatment and prevention of breast cancer. Every breast cancer treatment available today has been proven through clinical trials research. More than 1,000 researchers in 118 institutions across Australia and New Zealand, together with the organisation’s donors, are committed to the vision of no more lives cut short.


Contact details:

Sara McGregor

Media & PR Lead

M: 0424 591 241

E: [email protected]    

Media

More from this category

  • Medical Health Aged Care
  • 06/03/2026
  • 19:10
Claritas HealthTech Ltd

Claritas iPET(TM) Approved by Australia TGA to Supply the Medical Software Device for Image Processing Enabling Diagnostic Quality Images from Short Scan Time and/or Low Dose PET, PET-CT/MRI Scans

LONDON and SYDNEY, March 06, 2026 (GLOBE NEWSWIRE) -- Claritas NucMed Technologies Ltd (Claritas), a healthcare technology company specializing in state-of-the-art image enhancement, noise reduction, segmentation and quantification, and related AI technologies, is pleased to announce that the Australian regulatory agency for medicines and medical devices, namely, the Therapeutic Goods Administration (TGA) has approved the software device, Claritas iPET™ for supply in Australia.This clearance from TGA in Australia further expands the reach and use of Claritas iPET™, already cleared and used in several jurisdictions. This software tool which is agnostic to equipment type and manufacturer, and which integrates into existing hospital…

  • Medical Health Aged Care
  • 06/03/2026
  • 15:57
Dementia Australia

Cronulla comes together for people impacted by dementia

Friday 6 March 2026 Cronulla comes together for people impacted by dementia Cronulla community members tied up their laces and showed up in force last weekend for the 2026 Cronulla Memory Walk & Jog - throwing their support behind people impacted by dementia whilst getting active to improve their brain health. More than 760 people walked, ran and jogged to the finish line to raise an impressive total of $103,430. Dementia Australia CEO Professor Tanya Buchanan extended her gratitude to all who participated, volunteered and raised vital funds for the cause. “There was an incredible turnout from the Cronulla community…

  • Contains:
  • Media, Women
  • 06/03/2026
  • 15:00
Chiquita & Co PR

Award-winning Author Gabriella Pomare debuts ‘Breaking the Good Girl Blueprint’ keynote in the United States.

Key Facts: Award-winning author and family lawyer Gabriella Pomare to deliver ‘Breaking the Good Girl Blueprint’ keynote at Global SheTalks conference in California on…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.